240 related articles for article (PubMed ID: 8944256)
1. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand.
Songsivilai S; Dharakul T; Kanistanon D
Trans R Soc Trop Med Hyg; 1996; 90(5):505-7. PubMed ID: 8944256
[TBL] [Abstract][Full Text] [Related]
2. [Detection of hepatitis B virus DNA and hepatitis C virus RNA in human hepatocellular carcinoma by polymerase chain reaction].
Zhang H; Tang Y; Lu X
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):70-2. PubMed ID: 9206206
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand.
Barusrux S; Nanok C; Puthisawas W; Pairojkul C; Poovorawan Y
Asian Pac J Cancer Prev; 2012; 13 Suppl():83-7. PubMed ID: 23480769
[TBL] [Abstract][Full Text] [Related]
5. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
8. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
9. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
[TBL] [Abstract][Full Text] [Related]
13. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
[TBL] [Abstract][Full Text] [Related]
14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
15. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.
Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ
Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499
[TBL] [Abstract][Full Text] [Related]
16. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
18. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
